Yu X - Search Results

1

Ferroptosis: Final destination for cancer?

Ye Z, Liu W, Zhuo Q, Hu Q, Liu M, Sun Q, Zhang Z, Fan G, Xu W, Ji S, Yu X, Qin Y, Xu X. Ye Z, et al. Among authors: yu x. Cell Prolif. 2020 Mar;53(3):e12761. doi: 10.1111/cpr.12761. Epub 2020 Feb 25. Cell Prolif. 2020. PMID: 32100402 Free PMC article. Review.

2

Carbon nanotubes in cancer diagnosis and therapy.

Ji SR, Liu C, Zhang B, Yang F, Xu J, Long J, Jin C, Fu DL, Ni QX, Yu XJ. Ji SR, et al. Biochim Biophys Acta. 2010 Aug;1806(1):29-35. doi: 10.1016/j.bbcan.2010.02.004. Epub 2010 Feb 26. Biochim Biophys Acta. 2010. PMID: 20193746 Review.

3

Quantum dots in cancer therapy.

Luo G, Long J, Zhang B, Liu C, Ji S, Xu J, Yu X, Ni Q. Luo G, et al. Among authors: yu x. Expert Opin Drug Deliv. 2012 Jan;9(1):47-58. doi: 10.1517/17425247.2012.638624. Epub 2011 Dec 16. Expert Opin Drug Deliv. 2012. PMID: 22171712 Review.

4

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.

Ji S, Xu J, Zhang B, Yao W, Xu W, Wu W, Xu Y, Wang H, Ni Q, Hou H, Yu X. Ji S, et al. Among authors: yu x. Cancer Biol Ther. 2012 Feb 15;13(4):206-15. doi: 10.4161/cbt.13.4.18692. Cancer Biol Ther. 2012. PMID: 22354009

5

Management of a malignant case of solid pseudopapillary tumor of pancreas: a case report and literature review.

Ji S, Xu J, Zhang B, Xu Y, Liu C, Long J, Ni Q, Yu X. Ji S, et al. Among authors: yu x. Pancreas. 2012 Nov;41(8):1336-40. doi: 10.1097/MPA.0b013e31824d52c7. Pancreas. 2012. PMID: 22699200 Review.

6

Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.

Xu J, Zhu W, Xu W, Cui X, Chen L, Ji S, Qin Y, Yao W, Liu L, Liu C, Long J, Li M, Yu X. Xu J, et al. Among authors: yu x. Int J Oncol. 2013 Jun;42(6):2046-52. doi: 10.3892/ijo.2013.1901. Epub 2013 Apr 16. Int J Oncol. 2013. PMID: 23588667

7

Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy.

Wu CT, Xu WY, Liu L, Long J, Xu J, Ni QX, Liu C, Yu XJ. Wu CT, et al. Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):651-5. doi: 10.1016/s1499-3872(13)60102-2. Hepatobiliary Pancreat Dis Int. 2013. PMID: 24322752

8

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

Qin Y, Zhu W, Xu W, Zhang B, Shi S, Ji S, Liu J, Long J, Liu C, Liu L, Xu J, Yu X. Qin Y, et al. Among authors: yu x. Cancer Lett. 2014 Jun 1;347(2):225-32. doi: 10.1016/j.canlet.2014.02.013. Epub 2014 Feb 18. Cancer Lett. 2014. PMID: 24561118

9

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.

Yao W, Ji S, Qin Y, Yang J, Xu J, Zhang B, Xu W, Liu J, Shi S, Liu L, Liu C, Long J, Ni Q, Li M, Yu X. Yao W, et al. Among authors: yu x. Mol Cancer. 2014 Aug 7;13:187. doi: 10.1186/1476-4598-13-187. Mol Cancer. 2014. PMID: 25103363 Free PMC article.

10

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu YF, Xu J, Long J, Liu L, Ni QX, Yu XJ. Jiang JH, et al. Biochim Biophys Acta. 2015 Jan;1855(1):43-9. doi: 10.1016/j.bbcan.2014.11.004. Epub 2014 Nov 26. Biochim Biophys Acta. 2015. PMID: 25432020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32,068 results

Search Page